Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10613452 | Journal of Controlled Release | 2005 | 11 Pages |
Abstract
The application of protein therapeutics for long-term, localized delivery has been hindered by a lack of a delivery device that releases active protein at a concentration within their therapeutic window. A protein delivery system that uses an osmotic pressure delivery mechanism and a photocrosslinked biodegradable elastomer has been designed in an attempt to overcome this limitation. The elastomer is prepared through the UV initiated crosslinking of end terminal acrylated star-poly(ε-caprolactone-co-d,l-lactide). Interferon-γ (IFN-γ) was released from the optimum formulation at a constant rate of 23 ng/day over 21 days. A cell-based assay showed that over 83% of released IFN-γ was bioactive. Furthermore, it was demonstrated that bovine serum albumin co-lyophilized with IFN-γ was released at the same rate as IFN-γ. This delivery formulation may be clinically useful for sustained, local protein drug delivery applications.
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Frank Gu, Husam M. Younes, Ayman O.S. El-Kadi, Ronald J. Neufeld, Brian G. Amsden,